Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
International Journal of Molecular Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1107-3756 Online ISSN: 1791-244X
Journal Cover
March-2020 Volume 45 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
March-2020 Volume 45 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

The GSK‑3β/β‑catenin signaling pathway is involved in HMGB1‑induced chondrocyte apoptosis and cartilage matrix degradation

  • Authors:
    • Zhiyong Shu
    • Xiaogang Miao
    • Tainhua Tang
    • Peng Zhan
    • Langqing Zeng
    • Yuwen Jiang
  • View Affiliations / Copyright

    Affiliations: Department of Orthopedics, Zhuhai People's Hospital, Zhuhai, Guangdong 519000, P.R. China
    Copyright: © Shu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 769-778
    |
    Published online on: January 9, 2020
       https://doi.org/10.3892/ijmm.2020.4460
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Knee osteoarthritis (KOA) is a common joint disease with a high incidence rate among middle‑aged and elderly individuals. However, the precise underlying pathological mechanisms and effective treatment of this disease remain to be determined. To explore the effect of high mobility group box 1 (HMGB1) on chondrocyte apoptosis and catabolism, the ATDC5 cell line was cultured as an in vitro model for cartilage research. Cultured cells were treated with recombinant HMGB1 at different concentrations. Hoechst staining and flow cytometry demonstrated that HMGB1 administration significantly induced apoptosis of ATDC5 cells, which was the same as the effect of interleukin‑1β treatment. HMGB1 also induced cartilage matrix degradation, as shown by Alcian blue staining. Moreover, HMGB1 markedly upregulated the expression levels of matrix metallopeptidases (MMPs) and a disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS), while genetic silencing of HMGB1 significantly suppressed their expressions. The glycogen synthase kinase (GSK)‑3β/β‑catenin pathway was activated upon HMGB1 treatment. Pharmacological inhibitors or HMGB1 knockdown inactivated the GSK‑3β/β‑catenin pathway, inhibited the expression levels of downstream genes, including MMPs and ADAMTS, and attenuated the apoptosis of ATDC5 cells. Furthermore, the data demonstrated that HMGB1 promoted chondrocyte dysfunction via the regulation of estrogen sulfotransferase and Runt‑related transcription factor 2. Thus, the findings of the present study demonstrated that HMGB1 induces chondrocyte cell apoptosis via activation of GSK‑3β/β‑catenin and the subsequent expression of multiple targeted genes.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

View References

1 

Glyn-Jones S, Palmer AJ, Agricola R, Price AJ, Vincent TL, Weinans H and Carr AJ: Osteoarthritis. Lancet. 386:376–387. 2015. View Article : Google Scholar : PubMed/NCBI

2 

Ashford S and Williard J: Osteoarthritis: A review. Nurse Pract. 39:1–8. 2014. View Article : Google Scholar : PubMed/NCBI

3 

Ke X, Jin G, Yang Y, Cao X, Fang R, Feng X and Lei B: Synovial fluid HMGB-1 levels are associated with osteoarthritis severity. Clin Lab. 61:809–818. 2015. View Article : Google Scholar : PubMed/NCBI

4 

Wang X, Guo Y, Wang C and Yu H, Yu X and Yu H: MicroRNA-142-3p Inhibits chondrocyte apoptosis and inflammation in osteoarthritis by targeting HMGB1. Inflammation. 39:1718–1728. 2016. View Article : Google Scholar : PubMed/NCBI

5 

Snelling SJ, Davidson RK, Swingler TE, Le LT, Barter MJ, Culley KL, Price A, Carr AJ and Clark IM: Dickkopf-3 is upregulated in osteoarthritis and has a chondroprotective role. Osteoarthritis Cartilage. 24:883–891. 2016. View Article : Google Scholar :

6 

Ley C, Svala E, Nilton A, Lindahl A, Eloranta ML, Ekman S and Skiöldebrand E: Effects of high mobility group box protein-1, interleukin-1β, and interleukin-6 on cartilage matrix metabolism in three-dimensional equine chondrocyte cultures. Connective Tissue Res. 52:290–300. 2011. View Article : Google Scholar

7 

Puzovic V, Brcic I, Ranogajec I and Jakic-Razumovic J: Prognostic values of ETS-1, MMP-2 and MMP-9 expression and co-expression in breast cancer patients. Neoplasma. 61:439–446. 2014. View Article : Google Scholar : PubMed/NCBI

8 

Yin Y and Wang Y: Association of BMP-14 rs143383 ploymorphism with its susceptibility to osteoarthritis: A meta-analysis and systematic review according to PRISMA guideline. Medicine (Baltimore). 96:e74472017. View Article : Google Scholar

9 

Zhang RK, Li GW, Zhang DW, Yu B and Feng SY: Research of the expression of subchondral bone of Indian hedgehog with early experimental osteoarthritis induced by mechanical stress. Zhonghua yi xue za zhi (Chinese). 97:53–56. 2017.

10 

Xu W, Gao P, Zhang Y, Piao L and Dong D: microRNA-138 Induces Cell Survival and Reduces WNT/β-catenin signaling of osteoarthritis chondrocytes through NEK2. IUBMB Life. 71:1355–1366. 2019. View Article : Google Scholar : PubMed/NCBI

11 

Okura T, Ohkawara B, Takegami Y, Ito M, Masuda A, Seki T, Ishiguro N and Ohno K: Mianserin suppresses R-spondin 2-induced activation of Wnt/β-catenin signaling in chondrocytes and prevents cartilage degradation in a rat model of osteoarthritis. Sci Rep. 9:28082019. View Article : Google Scholar

12 

Fernandez-Torres J, Zamudio-Cuevas Y, Lopez-Reyes A, Garrido-Rodríguez D, Martínez-Flores K, Lozada CA, Muñóz-Valle JF, Oregon-Romero E and Martínez-Nava GA: Gene-gene interactions of the Wnt/β-catenin signaling pathway in knee osteoarthritis. Mol Biol Rep. 45:1089–1098. 2018. View Article : Google Scholar

13 

Sanchez-Adams J, Leddy HA, McNulty AL, O'Conor CJ and Guilak F: The mechanobiology of articular cartilage: Bearing the burden of osteoarthritis. Curr Rheumatol Rep. 16:4512014. View Article : Google Scholar : PubMed/NCBI

14 

Chen YC, Statt S, Wu R, Chang HT, Liao JW, Wang CN, Shyu WC and Lee CC: High mobility group box 1-induced epithelial mesenchymal transition in human airway epithelial cells. Sci Rep. 6:188152016. View Article : Google Scholar : PubMed/NCBI

15 

Jiang Y, Zhu L, Zhang T, Lu H, Wang C, Xue B, Xu X, Liu Y, Cai Z, Sang W, et al: BRD4 has dual effects on the HMGB1 and NF-κB signalling pathways and is a potential therapeutic target for osteoarthritis. Biochim Biophys Acta Mol Basis Dis. 1863:3001–3015. 2017. View Article : Google Scholar : PubMed/NCBI

16 

Zhang C, Yu W, Huang C, Ding Q, Liang C, Wang L, Hou Z and Zhang Z: Chrysin protects human osteoarthritis chondrocytes by inhibiting inflammatory mediator expression via HMGB1 suppression. Mol Med Rep. 19:1222–1229. 2019.

17 

Flemming A, Brummer T, Reth M and Jumaa H: The adaptor protein SLP-65 acts as a tumor suppressor that limits pre-B cell expansion. Nat Immunol. 4:38–43. 2003. View Article : Google Scholar

18 

Shen C, Cai GQ, Peng JP and Chen XD: Autophagy protects chondrocytes from glucocorticoids-induced apoptosis via ROS/Akt/FOXO3 signaling. Osteoarthritis Cartilage. 23:2279–2287. 2015. View Article : Google Scholar : PubMed/NCBI

19 

Hui W, Litherland GJ, Jefferson M, Barter MJ, Elias MS, Cawston TE, Rowan AD and Young DA: Lithium protects cartilage from cytokine-mediated degradation by reducing collagen-degrading MMP production via inhibition of the P38 mitogen-activated protein kinase pathway. Rheumatology (Oxford). 49:2043–2053. 2010. View Article : Google Scholar

20 

Li Y, Wang XY, Zhang ZL, Cheng X, Li XD, Chuai M, Lee KK, Kurihara H and Yang X: Excess ROS induced by AAPH causes myocardial hypertrophy in the developing chick embryo. Int J Cardiol. 176:62–73. 2014. View Article : Google Scholar : PubMed/NCBI

21 

He YQ, Li Y, Wang XY, He XD, Jun L, Chuai M, Lee KK, Wang J, Wang LJ, Yang X, et al: Dimethyl phenyl piperazine iodide (DMPP) induces glioma regression by inhibiting angio-genesis. Exp Cell Res. 320:354–364. 2014. View Article : Google Scholar

22 

Yavropoulou MP and Yovos JG: The role of the Wnt signaling pathway in osteoblast commitment and differentiation. Hormones (Athens). 6:279–294. 2007. View Article : Google Scholar

23 

Iwata M, Aikawa T, Hakozaki T, Arai K, Ochi H, Haro H, Tagawa M, Asou Y and Hara Y: Enhancement of Runx2 expression is potentially linked to beta-catenin accumulation in canine intervertebral disc degeneration. J Cell Physiol. 230:180–190. 2015. View Article : Google Scholar

24 

Vega OA, Lucero CMJ, Araya HF, Jerez S, Tapia JC, Antonelli M, Salazar-Onfray F, Las Heras F, Thaler R, Riester SM, et al: Wnt/β-catenin signaling activates expression of the bone-related transcription factor RUNX2 in select human osteosarcoma cell types. J Cell Biochem. 118:3662–3674. 2017. View Article : Google Scholar : PubMed/NCBI

25 

Andersson U and Tracey KJ: HMGB1 is a therapeutic target for sterile inflammation and infection. Annu Rev Immunol. 29:139–162. 2011. View Article : Google Scholar : PubMed/NCBI

26 

Nalesso G, Sherwood J, Bertrand J, Pap T, Ramachandran M, De Bari C, Pitzalis C and Dell'accio F: WNT-3A modulates articular chondrocyte phenotype by activating both canonical and noncanonical pathways. J Cell Biol. 193:551–564. 2011. View Article : Google Scholar : PubMed/NCBI

27 

Park SY, Lee SW, Kim HY, Lee WS, Hong KW and Kim CD: HMGB1 induces angiogenesis in rheumatoid arthritis via HIF-1α activation. Eur J Immunol. 45:1216–1227. 2015. View Article : Google Scholar

28 

Heinola T, Kouri VP, Clarijs P, Ciferska H, Sukura A, Salo J and Konttinen YT: High mobility group box-1 (HMGB-1) in osteoarthritic cartilage. Clin Exp Rheumatol. 28:511–518. 2010.PubMed/NCBI

29 

Takamatsu A, Ohkawara B, Ito M, Masuda A, Sakai T, Ishiguro N and Ohno K: Verapamil protects against cartilage degradation in osteoarthritis by inhibiting Wnt/β-catenin signaling. PLoS One. 9:e926992014. View Article : Google Scholar

30 

Yuan Z, Luo G, Li X, Chen J, Wu J and Peng Y: PPARgamma inhibits HMGB1 expression through upregulation of miR-142-3p in vitro and in vivo. Cell Signal. 28:158–164. 2016. View Article : Google Scholar : PubMed/NCBI

31 

Gardella S, Andrei C, Ferrera D, Lotti LV, Torrisi MR, Bianchi ME and Rubartelli A: The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway. Embo Rep. 3:995–1001. 2002. View Article : Google Scholar : PubMed/NCBI

32 

Garcia-Arnandis I, Guillen MI, Gomar F, Pelletier JP, Martel-Pelletier J and Alcaraz MJ: High mobility group box 1 potentiates the pro-inflammatory effects of interleukin-1β in osteoarthritic synoviocytes. Arthrit Res Ther. 12:R1652010. View Article : Google Scholar

33 

Garcia-Arnandis I, Guillen MI, Castejon MA, Gomar F and Alcaraz MJ: Haem oxygenase-1 down-regulates high mobility group box 1 and matrix metalloproteinases in osteoarthritic synoviocytes. Rheumatology (Oxford). 49:854–861. 2010. View Article : Google Scholar

34 

Ghosh S, Basu M and Roy SS: ETS-1 protein regulates vascular endothelial growth factor-induced matrix metalloproteinase-9 and matrix metalloproteinase-13 expression in human ovarian carcinoma cell line SKOV-3. J Biol Chem. 287:15001–15015. 2012. View Article : Google Scholar : PubMed/NCBI

35 

Ji Q, Xu X, Xu Y, Fan Z, Kang L, Li L, Liang Y, Guo J, Hong T, Li Z, et al: miR-105/Runx2 axis mediates FGF2-induced ADAMTS expression in osteoarthritis cartilage. J Mol Med (Berl). 94:681–694. 2016. View Article : Google Scholar

36 

Mekala LP, Mohammed M, Chintalapati S and Chintalapati VR: Stable isotope-assisted metabolic profiling reveals growth mode dependent differential metabolism and multiple catabolic pathways of l-phenylalanine in rubrivivax benzoatilyticus JA2. J Proteome Res. 17:189–202. 2018. View Article : Google Scholar

37 

Dell'Isola A, Allan R, Smith SL, Marreiros SS and Steultjens M: Identification of clinical phenotypes in knee osteoarthritis: A systematic review of the literature. BMC Musculoskelet Disord. 17:4252016. View Article : Google Scholar : PubMed/NCBI

38 

Arend WP and Dayer JM: Inhibition of the production and effects of interleukin-1 and tumor necrosis factor alpha in rheumatoid arthritis. Arthritis Rheum. 38:151–160. 1995. View Article : Google Scholar : PubMed/NCBI

39 

Nagase H and Woessner JF Jr: Matrix metalloproteinases. J Biol Chem. 274:21491–21494. 1999. View Article : Google Scholar : PubMed/NCBI

40 

Loeser RF, Yammani RR, Carlson CS, Chen H, Cole A, Im HJ, Bursch LS and Yan SD: Articular chondrocytes express the receptor for advanced glycation end products: Potential role in osteoarthritis. Arthritis Rheum. 52:2376–2385. 2005. View Article : Google Scholar : PubMed/NCBI

41 

Schulte G and Bryja V: WNT signalling: Mechanisms and therapeutic opportunities. Br J Pharmacol. 174:4543–4546. 2017. View Article : Google Scholar : PubMed/NCBI

42 

Xia C, Wang P, Fang L, Ge Q, Zou Z, Dong R, Zhang P, Shi Z, Xu R, Zhang L, et al: Activation of β-catenin in Col2-expressing chondrocytes leads to osteoarthritis-like defects in hip joint. J Cell Physiol. 234:18535–18543. 2019.PubMed/NCBI

43 

Nishimura R, Hata K and Kida J: Regulation of osteoblasts and chondrocytes by Wnt signaling. Clin Calcium (Japanese). 29:299–307. 2019.

44 

Ma L, Liu Y, Zhao X, Li P and Jin Q: Rapamycin attenuates articular cartilage degeneration by inhibiting β-catenin in a murine model of osteoarthritis. Connect Tissue Res. 60:452–462. 2019. View Article : Google Scholar : PubMed/NCBI

45 

Chen Y, Hu Y, Yang L, Zhou J, Tang Y, Zheng L and Qin P: Runx2 alleviates high glucose-suppressed osteogenic differentiation via PI3K/AKT/GSK3 β/β-catenin pathway. Cell Biol Int. 41:822–832. 2017. View Article : Google Scholar : PubMed/NCBI

46 

Deng L, Hu G, Jin L, Wang C and Niu H: Involvement of microRNA-23b in TNF-α-reduced BMSC osteogenic differentiation via targeting runx2. J Bone Miner Metab. 36:648–660. 2018. View Article : Google Scholar

47 

Cai T, Sun D, Duan Y, Wen P, Dai C, Yang J and He W: WNT/β-catenin signaling promotes VSMCs to osteogenic trans-differentiation and calcification through directly modulating Runx2 gene expression. Exp Cell Res. 345:206–217. 2016. View Article : Google Scholar : PubMed/NCBI

48 

Zhu YL, Wang S, Ding DG, Xu L and Zhu HT: miR217 inhibits osteogenic differentiation of rat bone marrowderived mesenchymal stem cells by binding to Runx2. Mol Med Rep. 15:3271–3277. 2017. View Article : Google Scholar : PubMed/NCBI

49 

Zhai KF, Duan H, Khan GJ, Xu H, Han FK, Cao WG, Gao GZ, Shan LL and Wei ZJ: Salicin from alangium chinense ameliorates rheumatoid arthritis by modulating the Nrf2-HO-1-ROS pathways. J Agric Food Chem. 66:6073–6082. 2018. View Article : Google Scholar : PubMed/NCBI

50 

Zhai KF, Duan H, Cao WG, Gao GZ, Shan LL, Fang XM and Zhao L: Protective effect of Rabdosia amethystoides (Benth) Hara extract on acute liver injury induced by Concanavalin A in mice through inhibition of TLR4-NF-κB signaling pathway. J Pharmacol Sci. 130:94–100. 2016. View Article : Google Scholar : PubMed/NCBI

51 

Zhai KF, Duan H, Luo L, Cao WG, Han FK, Shan LL and Fang XM: Protective effects of paeonol on inflammatory response in IL-β-induced human fibroblast-like synoviocytes and rheumatoid arthritis progression via modulating NF-kappaB pathway. Inflammopharmacology. Aug 10–2017.Epub ahead of print. View Article : Google Scholar

52 

Zhai KF, Duan H, Chen Y, Khan GJ, Cao WG, Gao GZ, Shan LL and Wei ZJ: Apoptosis effects of imperatorin on synoviocytes in rheumatoid arthritis through mitochondrial/caspase-mediated pathways. Food Funct. 9:2070–2079. 2018. View Article : Google Scholar : PubMed/NCBI

53 

Zhai KF, Duan H, Cui CY, Cao YY, Si JL, Yang HJ, Wang YC, Cao WG, Gao GZ and Wei ZJ: Liquiritin from Glycyrrhiza uralensis attenuating rheumatoid arthritis via reducing inflammation, suppressing angiogenesis, and inhibiting MAPK signaling pathway. J Agric Food Chem. 67:2856–2864. 2019. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Shu Z, Miao X, Tang T, Zhan P, Zeng L and Jiang Y: The GSK‑3β/β‑catenin signaling pathway is involved in HMGB1‑induced chondrocyte apoptosis and cartilage matrix degradation. Int J Mol Med 45: 769-778, 2020.
APA
Shu, Z., Miao, X., Tang, T., Zhan, P., Zeng, L., & Jiang, Y. (2020). The GSK‑3β/β‑catenin signaling pathway is involved in HMGB1‑induced chondrocyte apoptosis and cartilage matrix degradation. International Journal of Molecular Medicine, 45, 769-778. https://doi.org/10.3892/ijmm.2020.4460
MLA
Shu, Z., Miao, X., Tang, T., Zhan, P., Zeng, L., Jiang, Y."The GSK‑3β/β‑catenin signaling pathway is involved in HMGB1‑induced chondrocyte apoptosis and cartilage matrix degradation". International Journal of Molecular Medicine 45.3 (2020): 769-778.
Chicago
Shu, Z., Miao, X., Tang, T., Zhan, P., Zeng, L., Jiang, Y."The GSK‑3β/β‑catenin signaling pathway is involved in HMGB1‑induced chondrocyte apoptosis and cartilage matrix degradation". International Journal of Molecular Medicine 45, no. 3 (2020): 769-778. https://doi.org/10.3892/ijmm.2020.4460
Copy and paste a formatted citation
x
Spandidos Publications style
Shu Z, Miao X, Tang T, Zhan P, Zeng L and Jiang Y: The GSK‑3β/β‑catenin signaling pathway is involved in HMGB1‑induced chondrocyte apoptosis and cartilage matrix degradation. Int J Mol Med 45: 769-778, 2020.
APA
Shu, Z., Miao, X., Tang, T., Zhan, P., Zeng, L., & Jiang, Y. (2020). The GSK‑3β/β‑catenin signaling pathway is involved in HMGB1‑induced chondrocyte apoptosis and cartilage matrix degradation. International Journal of Molecular Medicine, 45, 769-778. https://doi.org/10.3892/ijmm.2020.4460
MLA
Shu, Z., Miao, X., Tang, T., Zhan, P., Zeng, L., Jiang, Y."The GSK‑3β/β‑catenin signaling pathway is involved in HMGB1‑induced chondrocyte apoptosis and cartilage matrix degradation". International Journal of Molecular Medicine 45.3 (2020): 769-778.
Chicago
Shu, Z., Miao, X., Tang, T., Zhan, P., Zeng, L., Jiang, Y."The GSK‑3β/β‑catenin signaling pathway is involved in HMGB1‑induced chondrocyte apoptosis and cartilage matrix degradation". International Journal of Molecular Medicine 45, no. 3 (2020): 769-778. https://doi.org/10.3892/ijmm.2020.4460
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team